DSM-Firmenich Future Growth
Future criteria checks 3/6
DSM-Firmenich is forecast to grow earnings and revenue by 43.7% and 4.3% per annum respectively. EPS is expected to grow by 43.8% per annum. Return on equity is forecast to be 5.4% in 3 years.
Key information
43.7%
Earnings growth rate
43.8%
EPS growth rate
Chemicals earnings growth | 35.2% |
Revenue growth rate | 4.3% |
Future return on equity | 5.4% |
Analyst coverage | Good |
Last updated | 18 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 13,821 | 953 | 1,094 | 1,992 | 18 |
12/31/2025 | 13,360 | 806 | 973 | 1,916 | 20 |
12/31/2024 | 12,818 | 471 | 839 | 1,706 | 20 |
6/30/2024 | 12,455 | -190 | 745 | 1,452 | N/A |
3/31/2024 | 11,541 | -424 | 659 | 1,359 | N/A |
12/31/2023 | 10,627 | -658 | 573 | 1,265 | N/A |
9/30/2023 | 9,686 | -456 | 434 | 1,112 | N/A |
6/30/2023 | 8,745 | -254 | 287 | 959 | N/A |
3/31/2023 | 8,568 | 100 | 301 | 962 | N/A |
12/31/2022 | 8,390 | 454 | 314 | 965 | N/A |
9/30/2022 | 9,582 | 837 | 412 | 1,056 | N/A |
6/30/2022 | 7,867 | 823 | 510 | 1,147 | N/A |
3/31/2022 | 7,568 | 822 | 680 | 1,287 | N/A |
12/31/2021 | 7,269 | 820 | 850 | 1,427 | N/A |
9/30/2021 | 7,955 | 660 | 884 | 1,507 | N/A |
6/30/2021 | 7,558 | 493 | 906 | 1,489 | N/A |
3/31/2021 | 7,572 | 423 | 906 | 1,497 | N/A |
12/31/2020 | 8,106 | 448 | 868 | 1,494 | N/A |
9/30/2020 | 7,960 | 510 | 809 | 1,434 | N/A |
6/30/2020 | 8,034 | 557 | 810 | 1,462 | N/A |
3/31/2020 | 9,011 | 722 | 826 | 1,471 | N/A |
12/31/2019 | 7,998 | 675 | 744 | 1,385 | N/A |
9/30/2019 | 8,272 | 820 | 766 | 1,399 | N/A |
6/30/2019 | 8,502 | 794 | 747 | 1,395 | N/A |
3/31/2019 | 9,124 | 934 | 612 | 1,282 | N/A |
12/31/2018 | 9,267 | 1,069 | 698 | 1,391 | N/A |
9/30/2018 | 9,235 | 984 | 657 | 1,310 | N/A |
6/30/2018 | 9,106 | 2,082 | 550 | 1,170 | N/A |
3/31/2018 | 8,908 | 1,942 | N/A | 1,110 | N/A |
12/31/2017 | 8,632 | 1,761 | N/A | 996 | N/A |
9/30/2017 | 8,471 | 1,676 | N/A | 993 | N/A |
6/30/2017 | 8,333 | 738 | N/A | 1,028 | N/A |
3/31/2017 | 8,166 | 711 | N/A | 1,077 | N/A |
12/31/2016 | 7,920 | 645 | N/A | 1,018 | N/A |
9/30/2016 | 7,831 | 588 | N/A | 958 | N/A |
6/30/2016 | 7,778 | 274 | N/A | 914 | N/A |
3/31/2016 | 7,749 | 214 | N/A | 811 | N/A |
12/31/2015 | 7,722 | 174 | N/A | 696 | N/A |
9/30/2015 | 7,607 | 66 | N/A | 800 | N/A |
6/30/2015 | 7,456 | 114 | N/A | 820 | N/A |
3/31/2015 | 7,245 | 115 | N/A | 867 | N/A |
12/31/2014 | 7,051 | 123 | N/A | 808 | N/A |
9/30/2014 | 7,415 | 112 | N/A | 866 | N/A |
6/30/2014 | 7,834 | 138 | N/A | 885 | N/A |
3/31/2014 | 8,362 | 182 | N/A | 1,010 | N/A |
12/31/2013 | 8,858 | 252 | N/A | 998 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ZX61 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).
Earnings vs Market: ZX61 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: ZX61 is expected to become profitable in the next 3 years.
Revenue vs Market: ZX61's revenue (4.3% per year) is forecast to grow slower than the German market (5.6% per year).
High Growth Revenue: ZX61's revenue (4.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ZX61's Return on Equity is forecast to be low in 3 years time (5.4%).